Loading...
Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases
The second messenger molecule 3’5’-cyclic adenosine monophosphate (cAMP) imparts several beneficial effects in lung diseases such as asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). While cAMP is bronchodilatory in asthma and COPD, it also displays anti-f...
Na minha lista:
| Udgivet i: | Curr Opin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529846/ https://ncbi.nlm.nih.gov/pubmed/32622335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2020.05.002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|